Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in Papua New Guinean children: A randomized controlled trial

Vaccine Reports

Volumn 6, Issue , 2016, Pages 36-43

  Aho, Celestine ^a,b   Michael, Audrey ^a   Yoannes, Mition ^a   Greenhill, Andrew ^a,c,d   Jacoby, Peter ^d   Reeder, John ^a,e   Pomat, William ^a,d   Saleu, Gerard ^a   Namuigi, Pioto ^a   Phuanukoonnon, Suparat ^a,f   Smith Vaughan, Heidi ^b   Leach, Amanda J ^b   Richmond, Peter ^g   Lehmann, Deborah ^d  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF BALLARAT   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e BURNET INSTITUTE   (Australia)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

7 Valent pneumococcal conjugate vaccine; Carriage; Neonate; Papua New Guinea; Pneumococcal serotype; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR; NASOPHARYNX; NEWBORN; OUTCOME ASSESSMENT; PAPUA NEW GUINEAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 85011380668     PISSN: 24057843     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vacrep.2016.08.002     Document Type: Article

References (32)

1. Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J.E., et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385 (2015), 430–440.
2. O'Brien, K.L., Wolfson, L.J., Watt, J.P., Henkle, E., Deloria-Knoll, M., McCall, N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374 (2009), 893–902.
3. Sun, W., Jacoby, P., Riley, T.V., Bowman, J., Leach, A.J., Coates, H., et al. Association between early bacterial carriage and otitis media in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia: a cohort study. BMC Infect. Dis., 12, 2012, 366.
4. Montgomery, J.M., Lehmann, D., Smith, T., Michael, A., Joseph, B., Lupiwa, T., et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in highland children of Papua New Guinea. Rev. Infect. Dis. 12:Suppl 8 (1990), S1006–S1016.
5. Gratten, M., Gratten, H., Poli, A., Carrad, E., Raymer, M., Koki, G., Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers. Biol. Neonate 50 (1986), 114–120.
6. Francis, J.P., Richmond, P.C., Pomat, W.S., Michael, A., Keno, H., Phuanukoonnon, S., et al. Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants. Clin. Vaccine Immunol. 16 (2009), 1633–1638.
7. Papua New Guinea Department of Health, Papua New Guinea Child Health Policy and Plan 2009–2020, Port Moresby: Department of Health, 2009.
8. Duke, T., Michael, A., Mgone, J., Frank, D., Wal, T., Sehuko, R., Etiology of child mortality in Goroka, Papua New Guinea: a prospective two-year study. Bull. WHO 80 (2002), 16–25.
9. Kakazo, M., Lehmann, D., Coakley, K., Gratten, H., Saleu, G., Taime, J., et al. Mortality rates and the utilization of health services during terminal illness in the Asaro Valley, Eastern Highlands Province, Papua New Guinea. PNG Med. J. 42 (1999), 13–26.
10. O'Brien, K.L., Millar, E.V., Zell, E.R., Bronsdon, M.A., Weatherholtz, R., Reid, R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomised trial. J. Infect. Dis. 196 (2007), 1211–1220.
11. Singleton, R., Wenger, J., Klejka, J.A., Bulkow, L.R., Thompson, A., Sarkozy, D., et al. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial. Pediatr. Infect. Dis. J. 32 (2013), 257–263.
12. Whitney, C.G., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., Lynfield, R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348 (2003), 1737–1746.
13. Cutts, F.T., Zaman, S.M., Enwere, G., Jaffar, S., Levine, O.S., Okoko, J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 (2005), 1139–1146.
14. Klugman, K.P., Madhi, S.A., Huebner, R.E., Kohberger, R., Mbelle, N., Pierce, N., et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349 (2003), 1341–1348.
15. Mbelle, N., Huebner, R.E., Wasas, A.D., Kimura, A., Chang, I., Klugman, K.P., Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180 (1999), 1171–1176.
16. Riley, I.D., Lehmann, D., Alpers, M.P., De C Marshall, T.F., Gratten, H., Smith, D., Pneumococcal vaccine prevents death from acute lower respiratory-tract infections in Papua New Guinean children. Lancet 2 (1986), 877–881.
17. Pomat, W.S., van den Biggelaar, A.H., Phuanukoonnon, S., Francis, J., Jacoby, P., Siba, P.M., et al. Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial. PLoS ONE, 8, 2013, e56698.
18. Phuanukoonnon, S., Reeder, J.C., Pomat, W.S., van den Biggelaar, A.H., Holt, P.G., Saleu, G., et al. A neonatal pneumococcal conjugate vaccine trial in Papua New Guinea: study population, methods and operational challenges. PNG Med. J. 53 (2010), 191–206 Available at: http://www.pngimr.org.pg/png_med_journal/sept-dec%202010%20a%20neonatal%20pneumococcal%20conjugate%20vaccine%20trials%20in%20png.pdf. Accessed 17 March 2016.
19. Papua New Guinea Department of Health. Standard treatment for common illnesses of children in Papua New Guinea. A manual for nurses, community health workers, health extension officers and doctors. Port Moresby: Department of Health; 2005.
20. Satzke, C., Turner, P., Virolainen-Julkunen, A., Adrian, P.V., Antonio, M., Hare, K.M., et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 32 (2013), 165–179.
21. Scott, J.A., Ojal, J., Ashton, L., Muhoro, A., Burbidge, P., Goldblatt, D., Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection. Clin. Infect. Dis. 53 (2011), 663–670.
22. Obaro, S.K., Adegbola, R.A., Banya, W.A., Greenwood, B.M., Carriage of pneumococci after pneumococcal vaccination. Lancet 348 (1996), 271–272.
23. Dunne, E.M., Manning, J., Russell, F.M., Robins-Browne, R.M., Mulholland, E.K., Satzke, C., Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J. Clin. Microbiol. 50 (2012), 1034–1038.
24. Smith-Vaughan, H., Byun, R., Nadkarni, M., Jacques, N.A., Hunter, N., Halpin, S., et al. Measuring nasal bacterial load and its association with otitis media. BMC Ear Nose Throat Disord., 6, 2006, 10.
25. Jacoby, P., Carville, K.S., Hall, G., Riley, T.V., Bowman, J., Leach, A.J., et al. Crowding and other strong predictors of upper respiratory tract carriage of otitis media-related bacteria in Australian Aboriginal and non-Aboriginal children. Pediatr. Infect. Dis. J. 30 (2011), 480–485.
26. Grimley, R., Chronic lung disease in a highland valley of Papua New Guinea [B Med Sci]. 1988, University of Queensland, Brisbane.
27. Kirarock, W.K., Oxidative stress and inflammatory responses in pregnant women and newborns exposed prenatally to high levels of indoor air pollution in the highlands of Papua New Guinea [Bachelor of Science Honours]. 2010, University of Papua New Guinea, Port Moresby.
28. Greenberg, D., Givon-Lavi, N., Broides, A., Blancovich, I., Peled, N., Dagan, R., The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin. Infect. Dis. 42 (2006), 897–903.
29. El Ahmer, O.R., Essery, S.D., Saadi, A.T., Raza, M.W., Ogilvie, M.M., Weir, D.M., et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol. Med. Microbiol. 23 (1999), 27–36.
30. Stubbs, E., Hare, K., Wilson, C., Morris, P., Leach, A.J., Streptococcus pneumoniae and noncapsular Haemophilus influenzae nasal carriage and hand contamination in children: a comparison of two populations at risk of otitis media. Pediatr. Infect. Dis. J. 24 (2005), 423–428.
31. Goldblatt, D., Hussain, M., Andrews, N., Ashton, L., Virta, C., Melegaro, A., et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192 (2005), 387–393.
32. Richmond, P., Pomat, W., Fuery, A., Francis, J., Opa, C., Siba, P., et al. Pneumococcal polysaccharide vaccine at 9 months of age is not associated with impaired B-cell memory or hyporesponsiveness in children in PNG [Abstract ISPPD - 0370]. Pneumonia, 3, 2014, 226.